Medulla Communications has entered the US market, appointing Andrew Schirmer as consulting director. The agency will focus on health-tech and consumer health brands, offering full-funnel marketing with US-led strategy and India-based execution. The expansion follows its Singapore launch and Capsule joint venture, strengthening Medulla’s growing global healthcare footprint.
Medulla Communications, one of India’s most awarded healthcare specialist agencies, has announced its official entry into the United States—marking another major milestone in its global expansion strategy. The agency has appointed industry veteran Andrew Schirmer as Consulting Director to lead US operations, signalling a strong commitment to serving America’s fast-growing health-tech and consumer health sectors.
The move reflects the agency’s sharpened focus on providing full-funnel marketing solutions, from lead generation and digital performance to brand building and long-term consumer engagement. Medulla’s strength lies in its unique hybrid model: US-level strategic expertise paired with India-based execution teams known for speed, technical depth, and cost efficiency.
For years, Medulla has already been supporting US-based health-tech startups remotely from its Mumbai office. These collaborations have ranged from digital-first consumer communication to performance-driven marketing campaigns. The formal entry into the US now gives the agency a local presence and strategic leadership—two elements that are increasingly essential in the competitive American health-tech landscape.
The expansion arrives just months after Medulla announced its entry into Singapore and launched Capsule, a joint venture positioned as India’s first super-specialised healthcare events agency. With the US now added to its footprint, Medulla is emerging as a global hub for healthcare brand communication across markets.
Speaking about the new chapter, Schirmer said the agency’s model resolves an issue long faced by emerging health-tech companies: “The era of health-tech brands and startups having to choose between market understanding and cost-effectiveness is over. Our model brings together the best of both worlds—US-based strategic leadership and India-based creative and digital execution that’s fast, technically sound, and cost-effective.”
As digital health adoption accelerates and consumer expectations evolve, Medulla’s entry into the US signals a timely opportunity. With health-tech brands seeking partners that understand both medical complexity and contemporary consumer behaviour, Medulla aims to position itself as the bridge between clinical credibility and creative storytelling.
For the healthcare marketing landscape, the agency’s arrival adds a specialist player uniquely equipped to operate across borders, budgets, and regulatory environments—strengthening its global narrative as a company built at the intersection of healthcare expertise and agile creative execution.
